Pharmaceutical News Wrap Up: March 2015

Interested in the latest pharmaceutical news? Simmons Hanly Conroy’s pharmaceutical attorneys understand the importance of staying up to date, which is why we’re providing the list of recent news stories below. Read about U.S. Food and Drug Administration (FDA) recalls, approvals and warning label changes, medical studies and other pharmaceutical news that took place in the month of March.

  • Drugs using testosterone will label heart risks
    pharmaceutical newsAs mentioned by Simmons Hanly Conroy attorneys earlier this month, the FDA has ordered testosterone manufacturers to update the labels to include warnings of increased risk of heart attacks and strokes. The update also describes how testosterone should not be prescribed to treat symptoms in men brought about by natural aging.
  • Statins increase risk of type 2 diabetes, study suggests
    A new study discovered that statins (drugs used to lower blood cholesterol) increase risk of type 2 diabetes by 46 percent. Researchers found that this is a result of decreases in insulin sensitivity and secretion.
  • FDA adds alcohol and seizure warnings to Pfizer’s quit-smoking pill
    The popular smoking cessation drug Chantix now flaunts a new safety alert warning from the FDA. The label warns consumers about its risk of seizures and dangers of taking the drug with alcohol.
Simmons Support Team
Simmons Hanly ConroyWritten by:

Editorial Team

The Simmons Hanly Conroy Editorial Team consists of journalists, writers and editors who strive to deliver accurate and useful information to families needing legal help. Our team works alongside the firm's attorneys and partners, as well as with medical professionals and other specialists, to keep all information relevant and helpful.